Grants and Contributions

The purpose of these funds is to provide the institution responsible for administering the Team Grant: Pan-Canadian Clinical Trials Consortium, with funding for indirect costs associated with hosting the CT Network as the Funding Opportunity was not eligible for consideration in the Research Support Fund program.

The specific objectives of this funding opportunity are to:

• Develop structured, openly accessible, and sustainable training and mentoring platforms that build capacity in the design, delivery, and analysis of clinical trials by:
o supporting the engagement of trainees, researchers, healthcare professionals and clinical research professionals in collaborative clinical trial training and mentoring opportunities across institutions, disciplines, jurisdictions and sectors;
o incorporating diverse training approaches, including experiential training opportunities;
o including diverse and inclusive approaches to training and mentoring (e.g., Indigenous Ways of Knowing) in a meaningful and culturally-safe manner; and
o implementing recruitment, training, and mentoring strategies to attract high-caliber trainees, researchers, healthcare professionals and clinical research professionals, including embedding and applying Equity, Diversity and Inclusion (EDI) best practices.
• Support the development of skills that increase the likelihood of employability and career prospects of trainees, researchers, healthcare professionals and clinical research professionals across sectors, by integrating training on:
o approaches to advance rigorous and responsible research (e.g., product development from discovery to commercialization; best practices in clinical trial design, recruitment, conduct and reporting; sex- and gender-based analysis plus [SGBA+] (WSC:#moreInformation); research data management, research involving Indigenous Peoples, ethics, unconscious bias, life cycle/life stage approaches to clinical trials);
o grant/proposal writing, budgeting, and peer review;
o Professional development skills (including transferrable skills, such as communication, analytical thinking, problem solving, project management, leadership, etc.);
o best practices in knowledge translation and implementation science; and
o diverse career options and opportunities available across the different sectors (private/for profit, public and not-for-profit).
• Support and contribute, where possible and relevant, to research funded through the Projects component (offered through separate funding opportunities) of the CTF and participate in the Pan-Canadian Clinical Trials Consortium once it is established.

The specific objectives of this funding opportunity are, in the context of the Biomanufacturing and Life Sciences Strategy, to:

• Support research teams across the country in conducting clinical trials that apply intersectional study design, primary data collection, and analyses so that the outcomes and health benefits of these trials can be applied to Canada’s diverse population;
• Support the participation of Canadian sites in international clinical trials;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The specific objectives of this funding opportunity are, in the context of the Biomanufacturing and Life Sciences Strategy, to:

• Support research teams across the country in conducting clinical trials that apply intersectional study design, primary data collection, and analyses so that the outcomes and health benefits of these trials can be applied to Canada’s diverse population;
• Support the participation of Canadian sites in international clinical trials;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The specific objectives of this funding opportunity are, in the context of the Biomanufacturing and Life Sciences Strategy, to:

• Support research teams across the country in conducting clinical trials that apply intersectional study design, primary data collection, and analyses so that the outcomes and health benefits of these trials can be applied to Canada’s diverse population;
• Support the participation of Canadian sites in international clinical trials;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The specific objectives of this funding opportunity are, in the context of the Biomanufacturing and Life Sciences Strategy, to:

• Support research teams across the country in conducting clinical trials that apply intersectional study design, primary data collection, and analyses so that the outcomes and health benefits of these trials can be applied to Canada’s diverse population;
• Support the participation of Canadian sites in international clinical trials;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The purpose of these funds is to provide the institution responsible for administering the Operating Grant: Clinical Trials Projects, with funding for indirect costs associated with hosting the CT Network as the Funding Opportunity was not eligible for consideration in the Research Support Fund program.

The purpose of these funds is to provide the institution responsible for administering the Operating Grant: Clinical Trials Projects, with funding for indirect costs associated with hosting the CT Network as the Funding Opportunity was not eligible for consideration in the Research Support Fund program.

The purpose of these funds is to provide the institution responsible for administering the Operating Grant: Clinical Trials Projects, with funding for indirect costs associated with hosting the CT Network as the Funding Opportunity was not eligible for consideration in the Research Support Fund program.

The specific objectives of this funding opportunity are, in the context of the Biomanufacturing and Life Sciences Strategy, to:

• Support research teams across the country in conducting clinical trials that apply intersectional study design, primary data collection, and analyses so that the outcomes and health benefits of these trials can be applied to Canada’s diverse population;
• Support the participation of Canadian sites in international clinical trials;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.